CHICAGO, Feb 27 (Reuters) - Healthcare products company Covidien said on Wednesday the U.S. Food and Drug Administration granted tentative approval for its generic imaging agent used for detecting coronary artery disease.
CHICAGO, Feb 27 (Reuters) - Healthcare products company Covidien said on Wednesday the U.S. Food and Drug Administration granted tentative approval for its generic imaging agent used for detecting coronary artery disease.